183 related articles for article (PubMed ID: 32037147)
41. Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis.
Nakashima C; Otsuka A; Kabashima K
Exp Dermatol; 2018 Apr; 27(4):327-331. PubMed ID: 29524262
[TBL] [Abstract][Full Text] [Related]
42. Galectin-9 Induced by Dietary Probiotic Mixture Regulates Immune Balance to Reduce Atopic Dermatitis Symptoms in Mice.
Kim HW; Ju DB; Kye YC; Ju YJ; Kim CG; Lee IK; Park SM; Choi IS; Cho KK; Lee SH; Kim SC; Jung ID; Han SH; Yun CH
Front Immunol; 2019; 10():3063. PubMed ID: 32038618
[TBL] [Abstract][Full Text] [Related]
43. The potential role of impaired Notch signalling in atopic dermatitis.
Melnik BC
Acta Derm Venereol; 2015 Jan; 95(1):5-11. PubMed ID: 24853951
[TBL] [Abstract][Full Text] [Related]
44. Chitinase 3-like 1 drives allergic skin inflammation via Th2 immunity and M2 macrophage activation.
Kwak EJ; Hong JY; Kim MN; Kim SY; Kim SH; Park CO; Kim KW; Lee CG; Elias JA; Jee HM; Sohn MH
Clin Exp Allergy; 2019 Nov; 49(11):1464-1474. PubMed ID: 31397016
[TBL] [Abstract][Full Text] [Related]
45. Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin.
Szegedi K; Lutter R; Res PC; Bos JD; Luiten RM; Kezic S; Middelkamp-Hup MA
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2136-44. PubMed ID: 25980674
[TBL] [Abstract][Full Text] [Related]
46. Mapping mouse IL-13 binding regions using structure modeling, molecular docking, and high-density peptide microarray analysis.
Madala SK; Dolan MA; Sharma D; Ramalingam TR; Wilson MS; Mentink-Kane MM; Masison DC; Wynn TA
Proteins; 2011 Jan; 79(1):282-93. PubMed ID: 21064130
[TBL] [Abstract][Full Text] [Related]
47. Interleukin 25, thymic stromal lymphopoietin and house dust mites in pathogenesis of atopic dermatitis.
Jaworek AK; Szafraniec K; Zuber Z; Wojas-Pelc A; Jaworek J
J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32776912
[TBL] [Abstract][Full Text] [Related]
48. Arjunolic acid protects against DNCB-induced atopic dermatitis-like symptoms in mice by restoring a normal cytokine balance.
Alyoussef A
Eur Cytokine Netw; 2015; 26(2):38-45. PubMed ID: 26553587
[TBL] [Abstract][Full Text] [Related]
49. IL-4 Augments IL-31/IL-31 Receptor Alpha Interaction Leading to Enhanced Ccl 17 and Ccl 22 Production in Dendritic Cells: Implications for Atopic Dermatitis.
Miake S; Tsuji G; Takemura M; Hashimoto-Hachiya A; Vu YH; Furue M; Nakahara T
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434203
[TBL] [Abstract][Full Text] [Related]
50. IL-31: a new link between T cells and pruritus in atopic skin inflammation.
Sonkoly E; Muller A; Lauerma AI; Pivarcsi A; Soto H; Kemeny L; Alenius H; Dieu-Nosjean MC; Meller S; Rieker J; Steinhoff M; Hoffmann TK; Ruzicka T; Zlotnik A; Homey B
J Allergy Clin Immunol; 2006 Feb; 117(2):411-7. PubMed ID: 16461142
[TBL] [Abstract][Full Text] [Related]
51. The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.
Skabytska Y; Kaesler S; Volz T; Biedermann T
Semin Immunopathol; 2016 Jan; 38(1):29-43. PubMed ID: 26573298
[TBL] [Abstract][Full Text] [Related]
52. Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines.
Boguniewicz M
J Allergy Clin Immunol Pract; 2017; 5(6):1477-1487. PubMed ID: 29122151
[TBL] [Abstract][Full Text] [Related]
53. Substance P restores normal skin architecture and reduces epidermal infiltration of sensory nerve fiber in TNCB-induced atopic dermatitis-like lesions in NC/Nga mice.
Choi H; Kim DJ; Nam S; Lim S; Hwang JS; Park KS; Hong HS; Won Y; Shin MK; Chung E; Son Y
J Dermatol Sci; 2018 Mar; 89(3):248-257. PubMed ID: 29269174
[TBL] [Abstract][Full Text] [Related]
54. Cytokines and T cells in atopic dermatitis.
Auriemma M; Vianale G; Amerio P; Reale M
Eur Cytokine Netw; 2013 Mar; 24(1):37-44. PubMed ID: 23608610
[TBL] [Abstract][Full Text] [Related]
55. The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation.
Gaspar K; Kukova G; Bunemann E; Buhren BA; Sonkoly E; Szollosi AG; Muller A; Savinko T; Lauerma AI; Alenius H; Kemeny L; Dieu-Nosjean MC; Stander S; Fischer JW; Ruzicka T; Zlotnik A; Szegedi A; Homey B
J Dermatol Sci; 2013 Jul; 71(1):12-21. PubMed ID: 23702389
[TBL] [Abstract][Full Text] [Related]
56. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis.
Akdis M; Simon HU; Weigl L; Kreyden O; Blaser K; Akdis CA
J Immunol; 1999 Jul; 163(1):466-75. PubMed ID: 10384150
[TBL] [Abstract][Full Text] [Related]
57. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases.
Leung DY
J Allergy Clin Immunol; 1995 Sep; 96(3):302-18; quiz 319. PubMed ID: 7560632
[TBL] [Abstract][Full Text] [Related]
58. Down-regulated SHARPIN may accelerate the development of atopic dermatitis through activating interleukin-33/ST2 signalling.
Tang L; Wang J; Zhu J; Liang Y
Exp Dermatol; 2018 Dec; 27(12):1328-1335. PubMed ID: 30230040
[TBL] [Abstract][Full Text] [Related]
59. Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues.
Brunner PM; Emerson RO; Tipton C; Garcet S; Khattri S; Coats I; Krueger JG; Guttman-Yassky E
Allergy; 2017 Dec; 72(12):2017-2025. PubMed ID: 28599078
[TBL] [Abstract][Full Text] [Related]
60. Innate immune regulates cutaneous sensory IL-13 receptor alpha 2 to promote atopic dermatitis.
Xiao S; Lu Z; Steinhoff M; Li Y; Buhl T; Fischer M; Chen W; Cheng W; Zhu R; Yan X; Yang H; Liu Y; Dou Y; Wang W; Wang J; Meng J
Brain Behav Immun; 2021 Nov; 98():28-39. PubMed ID: 34391816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
